Journal of Psoriasis and Psoriatic Arthritis

Aims & Scope

Journal of Psoriasis and Psoriatic Arthritis (JPPA) is a peer-reviewed specialty journal published by the National Psoriasis Foundation for its professional members and for dermatology and rheumatology specialists and community.

The purpose of the journal is to provide the latest research and practical treatment information about psoriasis, psoriatic arthritis and related comorbidities and conditions in a concise and easy-to-read format.

Medical professionals are invited to submit articles to be considered for publication.

View Aims & Scope

---

Metrics & Ranking

SJR (SCImago Journal Rank)

Year	Value
2024	0.351

Quartile

Year	Value
2024	Q3

h-index

Year	Value
2024	9

Journal Rank

Year	Value
2024	15125

Journal Citation Indicator

Year	Value
2024	64

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• TNF Inhibitor-Induced Psoriasis: Proposed Algorithm for Treatment and Management

  Citation: 94

  Authors: Sara Jiayang, Lourdes M., Joseph F.

• Machine Learning Applications in the Evaluation and Management of Psoriasis: A Systematic Review

  Citation: 50

  Authors: Kimberley, Maha N., Elena, Joel M.

• Pediatric Psoriatic Arthritis

  Citation: 30

  Authors: Timothy G., Cynthia K., Rui, Alexis, Pamela F.

• Biologic Treatment of 4 HIV-Positive Patients: A Case Series and Literature Review

  Citation: 24

  Authors: Bridget, Quinn, Vidhatha, Stephanie, Nicholas, Wilson, Tina

• 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis

  Citation: 19

  Authors: Jasvinder A., Gordon, Alexis, Dafna D., Chad, Atul, Maureen, Jonathan, M. Elaine, Sarah, Jennifer, Janice, Paula, Philip J., Joseph F., Julie, Christopher T., Bernadette, Benjamin J., Abby S., Anna Helena, Amit Aakash, Nancy, Marat, Laura C., Alice, Marina, W. Benjamin, Ana-Maria, Soumya M., Jose U., Evan, Michael, Jessica A., Amy S., James

• The Disease Burden of Generalized Pustular Psoriasis: Real-World Evidence From CorEvitas’ Psoriasis Registry

  Citation: 19

  Authors: M, R A., R H., L R., W C., M, A K., N, B

• Clinical Characteristics and HealthCare Resource Utilization in Patients With Generalized Pustular Psoriasis: Real-World Evidence From a Large Claims-Based Dataset

  Citation: 18

  Authors: Jeffrey, Amanda K., Nirali, Ran, Rhonda L., Elizabeth M., Julia A., Wendell C., Steven R., Alan

• Gender Differences in Psoriatic Arthritis With Fatigue, Pain, Function, and Work Disability

  Citation: 18

  Authors: Tawnie J., Chong, Angela P., Brian, Daniel, Jessica A.

• Deucravacitinib: A Novel TYK2 Inhibitor for the Treatment of Moderate-to-Severe Psoriasis

  Citation: 17

  Authors: Paige, Andrew, Bruce, April W.

• Guselkumab for the Treatment of Moderate-to-Severe Plaque Psoriasis During Induction Phase: A Systematic Review and Network Meta-Analysis

  Citation: 16

  Authors: C., C., B., S., S., A., A., A., R.

---